Phase I Trial of Sorafenib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma.

Journal of Clinical Oncology - United States
doi 10.1200/jco.2015.33.3_suppl.401
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)